These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 18591484)

  • 61. Schizophrenia-like attentional deficits following blockade of prefrontal cortex GABAA receptors.
    Paine TA; Slipp LE; Carlezon WA
    Neuropsychopharmacology; 2011 Jul; 36(8):1703-13. PubMed ID: 21490590
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
    Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Age-related differences in frontal lobe function in children with ADHD.
    Yasumura A; Omori M; Fukuda A; Takahashi J; Yasumura Y; Nakagawa E; Koike T; Yamashita Y; Miyajima T; Koeda T; Aihara M; Inagaki M
    Brain Dev; 2019 Aug; 41(7):577-586. PubMed ID: 30952459
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Neurobiological bases of autistic spectrum disorder and attention deficit hyperactivity disorder: neural differentiation and synaptogenesis].
    Martinez-Morga M; Quesada-Rico MP; Bueno C; Martinez S
    Rev Neurol; 2018 Mar; 66(S01):S97-S102. PubMed ID: 29516460
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neurobehavioral and hemodynamic evaluation of Stroop and reverse Stroop interference in children with attention-deficit/hyperactivity disorder.
    Yasumura A; Kokubo N; Yamamoto H; Yasumura Y; Nakagawa E; Kaga M; Hiraki K; Inagaki M
    Brain Dev; 2014 Feb; 36(2):97-106. PubMed ID: 23414618
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation.
    Mortimer N; Ganster T; O'Leary A; Popp S; Freudenberg F; Reif A; Soler Artigas M; Ribasés M; Ramos-Quiroga JA; Lesch KP; Rivero O
    Neuropharmacology; 2019 Sep; 156():107557. PubMed ID: 30849401
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.
    Rastmanesh R
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):149-57. PubMed ID: 21432601
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes in the second messenger cyclic AMP during development may underlie motoric symptoms in attention deficit/hyperactivity disorder (ADHD).
    Andersen SL
    Behav Brain Res; 2002 Mar; 130(1-2):197-201. PubMed ID: 11864735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacological and therapeutic directions in ADHD: Specificity in the PFC.
    Levy F
    Behav Brain Funct; 2008 Feb; 4():12. PubMed ID: 18304369
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selective activation of Dopamine D3 receptors and norepinephrine transporter blockade enhances sustained attention.
    Marshall CA; Brodnik ZD; Mortensen OV; Reith MEA; Shumsky JS; Waterhouse BD; España RA; Kortagere S
    Neuropharmacology; 2019 Apr; 148():178-188. PubMed ID: 30633928
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chemogenetic approach to model hypofrontality.
    Peña ID; Shi WX
    Med Hypotheses; 2016 Aug; 93():113-6. PubMed ID: 27372868
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Behavioural treatment increases activity in the cognitive neuronal networks in children with attention deficit/hyperactivity disorder.
    Siniatchkin M; Glatthaar N; von Müller GG; Prehn-Kristensen A; Wolff S; Knöchel S; Steinmann E; Sotnikova A; Stephani U; Petermann F; Gerber WD
    Brain Topogr; 2012 Jul; 25(3):332-44. PubMed ID: 22392009
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Methylphenidate administration reverts attentional inflexibility in adolescent rats submitted to a model of neonatal hypoxia-ischemia: Predictive validity for ADHD study.
    Miguel PM; Deniz BF; Confortim HD; Bronauth LP; de Oliveira BC; Alves MB; Silveira PP; Pereira LO
    Exp Neurol; 2019 May; 315():88-99. PubMed ID: 30771298
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys.
    Ma CL; Arnsten AF; Li BM
    Biol Psychiatry; 2005 Jan; 57(2):192-5. PubMed ID: 15652880
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Altered resting-state frontoparietal control network in children with attention-deficit/hyperactivity disorder.
    Lin HY; Tseng WY; Lai MC; Matsuo K; Gau SS
    J Int Neuropsychol Soc; 2015 Apr; 21(4):271-84. PubMed ID: 25928822
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder.
    Makris N; Biederman J; Valera EM; Bush G; Kaiser J; Kennedy DN; Caviness VS; Faraone SV; Seidman LJ
    Cereb Cortex; 2007 Jun; 17(6):1364-75. PubMed ID: 16920883
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
    Gronier B
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance.
    Zahrt J; Taylor JR; Mathew RG; Arnsten AF
    J Neurosci; 1997 Nov; 17(21):8528-35. PubMed ID: 9334425
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Specific cognitive-neurophysiological processes predict impulsivity in the childhood attention-deficit/hyperactivity disorder combined subtype.
    Bluschke A; Roessner V; Beste C
    Psychol Med; 2016 Apr; 46(6):1277-87. PubMed ID: 26803921
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans.
    Reif A; Jacob CP; Rujescu D; Herterich S; Lang S; Gutknecht L; Baehne CG; Strobel A; Freitag CM; Giegling I; Romanos M; Hartmann A; Rösler M; Renner TJ; Fallgatter AJ; Retz W; Ehlis AC; Lesch KP
    Arch Gen Psychiatry; 2009 Jan; 66(1):41-50. PubMed ID: 19124687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.